Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Gala vs Ro

Gala and Ro sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Gala logo

Gala

8.7
★★★★☆4.4/5

Best for: moving between compounded and brand without changing seller

Visit Gala →
VS
Ro logo

Ro

6.7
★★★☆☆3.4/5

Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC

Visit Ro →

If you are choosing between Gala and Ro, price alone will not settle it. Gala leads our six-part score, 8.7 to 6.7.

Gala vs Ro price

Gala and Ro start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Medications and formats

Gala and Ro do not overlap on medication; only Gala lists semaglutide and tirzepatide; only Ro lists orforglipron.

On format, Gala prices compounded injections and brand-name pens, while Ro prices brand-name pens.

Where each one treats patients

Gala lists 50 states, and Ro does not publish where it ships.

Pricing

Gala

Compounded GLP-1 (all doses)Compounded
$179$129/mo
Save 28% right now
semaglutide

$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.

Compounded GLP-1/GIP (all doses)Compounded
$179/mo
tirzepatide

$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.

Microdosing GLP-1/GIPCompounded
$149/mo
tirzepatide

$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'

Ozempic (brand)Brand-name
$1299/mo
semaglutide

'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).

Ro

Foundayo (lowest dose, cash pay)Brand-name
$149/mo
orforglipron

Additional membership fees apply

What each price covers

Both prices cover the clinician visit.

Gala's price also covers the medication itself and shipping, which Ro does not claim.

Ro's price also covers lab work and coaching, which Gala does not claim.

Gala is silent on lab work and coaching.

Ro is silent on shipping.

That matters most for the drug: unless Ro confirms otherwise, budget for medication on top of its listed price.

Gala

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Ro

Covered by the monthly price

Medication

Charged on top

Clinician visits

In the price

Shipping

Not stated

Lab work

In the price

Coaching

In the price

Where each one scores higher

Overall, Gala scores 8.7 and Ro 6.7 out of 10.

Gala is stronger on value (8.7 vs 5.0), effectiveness (10.0 vs 8.0), accessibility (10.0 vs 5.0) and support (7.0 vs 5.5).

Ro is stronger on trust & safety (8.0 vs 7.5).

User experience is within half a point.

How we score

Gala

8.7/10

Overall

Ro

6.7/10

Value25%

8.7A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
8.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
8.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
5.5

FDA warning letters

Neither Gala nor Ro has an FDA warning letter on record with us.

Features & Coverage

FeatureGalaRo
Starting Price$149/mo$149/mo
Features7 features7 features
States Available50Not disclosed
Compounded✓ Yes—
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Gala

A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.

Read our full Gala review →

About Ro

Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.

Read our full Ro review →

Pros & Cons

Gala

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gala

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Ro

What we like

  • Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes clinician visits, lab work and coaching
  • Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
  • We found no FDA warning letters issued to Ro

Watch-outs

  • Not included in the monthly price: medication
  • Confirm it serves your state before you start the intake

Our Verdict

Winner: Gala

Gala wins this one, 8.7 to 6.7, above all for moving between compounded and brand without changing seller. Ro fits better if knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC is your priority.

Choose Gala if…

You want moving between compounded and brand without changing seller and an opening price near $149 a month.

Choose Ro if…

You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.6

Willow

Seeing what it charges before you answer any medical questions

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

Gala vs Ro: FAQ

Neither on the entry price: Gala and Ro both start at about $149 a month. The difference is in what the price includes.
No. Gala lists semaglutide and tirzepatide; Ro lists orforglipron.
Gala lists 50 states; Ro does not publish where it ships. Confirm your state before paying.
Both include the clinician visit. Only Gala includes the medication itself and shipping. Only Ro includes lab work and coaching.
Gala has none. Ro has none.
Gala pays us a commission on sign-ups through our links; Ro does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.